Produktinformation
PF-06815345 is a kinetic convertase inhibitor that binds to the active site of the enzyme, inhibiting its activity. This compound has been shown to inhibit human low-density lipoprotein (LDL) cholesterol production in vitro and reduce plasma LDL-cholesterol levels in vivo. The mechanism of action of PF-06815345 is not clear, but it may be due to inhibition of statin catalysis, which leads to a decrease in the level of functional LDL receptors on liver cells. The drug also inhibits the activity of serine proteases such as subtilisin and kexin type enzymes. In addition, PF-06815345 has been shown to be an organocatalyst for low-temperature aldehyde synthesis, with tetrazole as a key intermediate. It is also used for treatment of cardiovascular diseases such as high blood pressure and elevated levels of low density lipoprotein cholesterol (LDL-C).
Chemische Eigenschaften
Technische Anfrage zu: 3D-JTD43449 PF-06815345
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
